Regulatory Affairs Excellence: U.S. & Global Staff and Spend Benchmarks by Submission Type for Medical Device Companies

STUDY OVERVIEW

Faced with the monumental task of ensuring that companies comply with the plethora of global regulations pertaining to developing and marketing medical device products, Regulatory Affairs groups rely on their own internal effectiveness and efficiencies to remain productive. Optimal resourcing and staffing help Regulatory Affairs groups in the medical device industry prioritize roles and responsibilities that will be most beneficial to growth.

Best Practices, LLC conducted this benchmarking study to establish meaningful metrics around Regulatory Affairs' spend, FTEs and consultants for medical device operations in the U.S. and globally. Staff and budget benchmarks are presented per Class I, II and III device products on the market, submissions actively maintained in 2010 and product applications submitted in 2010.

This metrics-heavy study presents spend, FTE and consultant ratios and benchmarks across regions and product types for the medical device industry. Specifically, the research includes spend, FTE and consultant ratios and benchmarks for Class I, II and III products on the market, with ratio data presented as spend per Class I, II and III product, FTEs per Class I, II and III product and consultants per Class I, II and III product.

In addition, the study contains spend, FTE and consultant benchmarks for regulatory submissions being actively maintained in the U.S., Canada, the EU and Japan during 2010. The same regional data is presented for regulatory submissions in 2010.

Medical device regulatory leaders can use this study to compare their spend, FTE and consultant ratios and benchmarks (per product type and by region) with those of leading medical device companies.

KEY TOPICS

• Executive Summary
• Participant Background
• Regulatory Ratios and Benchmarks for Class I, II, II Products on the Market
• Regional Regulatory Benchmarks for Spend, FTEs and Consultants

• Number of products on the market, Class I, II and III
• Global Regulatory Spend per Class I, II and III products and per device family
• Global Regulatory FTEs per Class I, II and III products and per device family
• Global Regulatory Consultants per Class I, II and III products and per device family
• Number of countries where products sold - regulatory spend, FTEs and consultants per country
• Regulatory Spend, FTEs and Consultants per U.S. submission being actively maintained
• Regulatory Spend, FTEs and Consultants per Japanese submissions being actively maintained
• Regulatory Spend, FTEs and Consultants per Canadian submissions being actively maintained
• Regulatory Spend, FTEs and Consultants per EU submissions being actively maintained
• Regulatory Spend, FTEs and Consultants per U.S. submissions in 2010
• Regulatory Spend, FTEs and Consultants per Japanese submissions in 2010
• Regulatory Spend, FTEs and Consultants per Canadian submissions in 2010
• Regulatory Spend, FTEs and Consultants per EU submissions in 2010
• Percent increase in past three years for U.S. Japanese, Canadian, EU regulatory filings
  

Regulatory Affairs Reporting Relationship: For 38% of companies, the Regulatory Affairs function reports to C-level management, or the highest level of senior management. For more than one-third of companies, the Regulatory Affairs function reports into a combined Quality and Regulatory Affairs executive.

Filing Trends: During the past three years, more than half the benchmark class saw increases in 30-day and 180-day supplements, 510(k)s, and Canadian licenses. Overall, non-U.S. filings have increased significantly for 63% of the benchmark class.

METHODOLOGY

For this benchmarking study, Best Practices®, LLC gathered insights and performance data from eight regulatory leaders representing eight leading medical device organizations. In addition, executive interviews were conducted with selected participants to produce qualitative insights.

Industries Profiled:
Consumer Products; Medical Device; Chemical; Technology; Health Care; Pharmaceutical; Orthopaedics


Companies Profiled:
Bausch & Lomb; Edwards Lifesciences; BD; Roche Diagnostics; Boston Scientific; Ethicon; Johnson & Johnson; Medtronic; Zimmer

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.